Rhythm Biosciences Ltd has released a press release.
ColoSTAT Kits Deliver Breakthrough Results
Filed with ASX ·
6ix hasn’t read this filing yet.
Rhythm Biosciences Limited on 6ix
Earlier from Rhythm Biosciences
- Jun 25 Quarterly Activities Report and Appendix 4C
- FY2025 R&D Tax Incentive Loan Funding
- NATA Accreditation Awarded for Genetype Laboratory
- ColoSTAT Beta kit verification and validation update
- Breast Cancer Risk Study University of Melbourne
Later from Rhythm Biosciences
- Response to ASX Price Query
- Placement Issue Investor Presentation
- Share Placement to Raise Up To $3.75 million
- Placement Prospectus
- ColoSTAT Kit Validation Completion and NATA Submission
Follow Rhythm Biosciences into a list and get an email when it puts out news.
Follow Rhythm Biosciences